ABOUT US

The Sohn Conference Foundation is dedicated to supporting innovative initiatives.

The Foundation funds groundbreaking research, state-of-the-art technology, and programs to target cures and improve patient care.

Sohn Foundation Initiatives

The Rockefeller University

The Rockefeller University is the world’s leading biomedical research university, Rockefeller draws top scientists and graduate students from around the world in pursuit of one mission: to conduct science for the benefit of humanity.

Uniquely among research institutes, Rockefeller has maintained its leadership position in biomedical research for more than a century, thanks to a culture built on unsurpassed excellence, the fostering of transformative basic science, and the application of science to the great medical problems facing humanity. Since its founding in 1901, the University has made essential contributions to biomedicine that have been recognized the world over.

The accelerating progress in the biological sciences means that we can look forward to understanding—with a resolution that was unimaginable just a few decades ago—how the cell works and how the brain works, and how the organism develops, fights infection, regenerates itself, and ages. This knowledge is also fueling a revolution in molecular medicine, opening new therapeutic possibilities for many elusive diseases, including cancer, autoimmune disorders, metabolic conditions, and neurodegenerative and psychiatric disorders. Rockefeller scientists will continue to be at the forefront of discoveries that will revolutionize our understanding of basic biological mechanisms, and they will lead in translating those discoveries into treatments and cures for serious diseases.

The Rockefeller University The Sohn Conference Foundation has funded Rockefeller’s acquisition of a high-performance supercomputer, equipment pivotal to scientists at the frontlines of discovery. In 2020 and 2021, Sohn also helped fund novel monoc — **The Rockefeller University**

The Sohn Conference Foundation has funded Rockefeller’s acquisition of a high-performance supercomputer, equipment pivotal to scientists at the frontlines of discovery. In 2020 and 2021, Sohn also helped fund novel monoclonal antibody therapy for COVID-19.

Artworks
Creative and performing arts programs for children and young adults, serving 35 hospitals in the New York Metropolitan area. — **Artworks**
Creative and performing arts programs for children and young adults, serving 35 hospitals in the New York Metropolitan area.

Columbia University Medical Center The only initiative of its kind, The Sohn Precision Medicine Program at Columbia UMC ensures all high-risk pediatric cancer patients from NYC have access to precision medicine via Columbia’s advanced diagnostic g — **Columbia University Medical Center**
The only initiative of its kind, The Sohn Precision Medicine Program at Columbia UMC ensures all high-risk pediatric cancer patients from NYC have access to precision medicine via Columbia’s advanced diagnostic genomic testing.

MSK Kids State-of-the-art equipment to help scientists study the epigenetics of leukemia; plus, funding for an innovative antibody clinical trial for neuroblastoma. — **MSK Kids**
State-of-the-art equipment to help scientists study the epigenetics of leukemia; plus, funding for an innovative antibody clinical trial for neuroblastoma.

NYU Langone

Funding for a brain diagnostic tumor program available at no other institution, with an emphasis on ensuring its availability for NYC children; plus, funding for a brand new children’s hospital, with special rooms for children with cancer.

Damon Runyon Cancer Research Foundation The Damon Runyon-Sohn Pediatric Cancer Fellowship Award funds basic scientists and clinicians who conduct research with the potential to significantly impact the prevention, diagnosis or treatment of one or m — **Damon Runyon Cancer Research Foundation**
The Damon Runyon-Sohn Pediatric Cancer Fellowship Award funds basic scientists and clinicians who conduct research with the potential to significantly impact the prevention, diagnosis or treatment of one or more pediatric cancers.

Mount Sinair Kravis Children's Hospital
The Lion’s Den provides a safe and technology-enabled center for children and teenagers being treated for cancer. — **Mount Sinair Kravis Children's Hospital**
The Lion’s Den provides a safe and technology-enabled center for children and teenagers being treated for cancer.

New York Genome Center The Sohn Collaborative Research Project for Pediatric Cancer brings together elite researchers from Columbia University, Memorial Sloan Kettering, NYU Langone, Rockefeller University, and Weill Cornell to tackle unanswered q — **New York Genome Center**

The Sohn Collaborative Research Project for Pediatric Cancer brings together elite researchers from Columbia University, Memorial Sloan Kettering, NYU Langone, Rockefeller University, and Weill Cornell to tackle unanswered questions about the genomics of pediatric cancer.

Pershing Square Cancer Research Provides top New York-based scientists the freedom to take risks and pursue their boldest research at a stage when traditional funding is lacking. — **Pershing Square Cancer Research**
Provides top New York-based scientists the freedom to take risks and pursue their boldest research at a stage when traditional funding is lacking.

Weill Cornell Medicine Funding to provide state-of-the-art research equipment to examine cancer metastasis and potential targets for new therapies. — **Weill Cornell Medicine**
Funding to provide state-of-the-art research equipment to examine cancer metastasis and potential targets for new therapies.

Hackensack University Medical Center The Sohn-Manning Pediatric Cancer Survivorship Program at HackensackUMC launched in 2016. The Children’s Cancer Institute at HackensackUMC focuses on the long term emotional and social issues specific to pediatr — **Hackensack University Medical Center**
The Sohn-Manning Pediatric Cancer Survivorship Program at HackensackUMC launched in 2016. The Children’s Cancer Institute at HackensackUMC focuses on the long term emotional and social issues specific to pediatric cancer survivors, as well as finding a cure with more than 100 active clinical trials. Sohn recognizes Eli Manning's leadership in helping HackensackUMC tackle kids cancer from all angles.

New York Presbyterian
Provided seed funding for the complete renovation of the Pediatric Infusion Center for outpatients to receive treatment in a space specially designed for children. — **New York Presbyterian**
Provided seed funding for the complete renovation of the Pediatric Infusion Center for outpatients to receive treatment in a space specially designed for children.

Tri-Institutional Therapeutics Discovery Institute Funding for collaborative research into leukemia and melanoma conducted within the unique drug discovery consortium of Memorial Sloan Kettering Cancer Center, Rockefeller University, and Weill Cor — **Tri-Institutional Therapeutics Discovery Institute**

Funding for collaborative research into leukemia and melanoma conducted within the unique drug discovery consortium of Memorial Sloan Kettering Cancer Center, Rockefeller University, and Weill Cornell Medical College.

Board of Directors

Graham Duncan Chairman & CEO — **Graham Duncan**
*Chairman & CEO*

Daniel Nir Co-Founder & President — **Daniel Nir**
*Co-Founder & President*

Evan Sohn Co-Founder, Vice President, & Treasurer — **Evan Sohn**
*Co-Founder & Vice President*

Douglas Hirsch Co-Founder & Chair Emeritus — **Douglas Hirsch**
*Co-Founder & Chair Emeritus*

With gratitude and appreciation, The Foundation recognizes Douglas Hirsch’s founding of The Sohn Conference Foundation and 24 years of service.

In Memory of Ira

The Foundation honors the memory of Ira Sohn, a talented Wall Street professional whose life was cut short when he passed away from cancer at the age of 29. In 1995, Ira’s friends Douglas Hirsch, Lance Laifer and Daniel Nir, along with Ira’s mother Judith Sohn and brother Evan, created The Sohn Conference Foundation.